NCT02788916 A Retrospective Study of Clinical, Phenotypic and Genetic Factors of Peripheral T-Cell Lymphomas Status COMPLETED Phase N/A
NCT02774902 TAK-438_110 Drug Interaction With Cytochrome P450 3A4 (CYP3A4) Inhibitor Clarithromycin Status COMPLETED Phase PHASE1
NCT02771093 An Exploratory Study of the Effects of Trelagliptin and Alogliptin on Glucose Variability in Patients With Type 2 Diabetes Mellitus Status COMPLETED Phase PHASE4
NCT02769065 Study of TAK-071 in Healthy Participants and Participants With Mild Cognitive Impairment/Mild Alzheimer Disease and Relative Bioavailability (BA) and Food Effect of TAK-071 in Healthy Participants Status TERMINATED Phase PHASE1
NCT02768532 Value of Pharmacokinetic Assays in the Prediction of Induction and Maintenance Therapeutic Response in Crohn's Disease Status TERMINATED Phase PHASE4
NCT02764762 Triple Combination Therapy in High Risk Crohn's Disease (CD) Status COMPLETED Phase PHASE4
NCT02764619 Inhibition of Aldosterone to Reduce Myocardial Diffuse Fibrosis in Patients With Paroxysmal and Persistent Atrial Fibrillation in Preventing Recurrent Episodes of Atrial Fibrillation Status UNKNOWN Phase PHASE3
NCT02761187 An Observational Study of Presentation, Treatment Patterns, and Outcomes in Multiple Myeloma Participants Status TERMINATED Phase N/A
NCT02760615 Phase 4, Vedolizumab-4002 Post-marketing, Disease-Drug-Drug Interaction Study Status WITHDRAWN Phase PHASE4
NCT02756832 An Observational Study of Alogliptin Benzoate in Participants With Diabetes Mellitus Type 2 Status COMPLETED Phase N/A
NCT02756819 International Multicenter, Observational, Non-Interventional Prospective Study of Azilsartan Medoxomil in Participants With Arterial Hypertension Who Are Overweight or Obese in the Russian Federation and The Republic of Kazakhstan Status COMPLETED Phase N/A
NCT02748694 Phase 1 TAK-041 First-in-Human Safety, Tolerability, and Pharmacokinetics Study Status COMPLETED Phase PHASE1
NCT02747927 Efficacy, Safety and Immunogenicity of Takeda's Tetravalent Dengue Vaccine (TDV) in Healthy Children Status COMPLETED Phase PHASE3
NCT02743949 Comparison of Vonoprazan to Esomeprazole in Participants With Symptomatic GERD Who Responded Partially to a High Dose of Proton Pump Inhibitor (PPI) Status COMPLETED Phase PHASE2
NCT02743806 Extended Access Program of Vedolizumab IV in Ulcerative Colitis and Crohn's Disease Status TERMINATED Phase PHASE4
NCT02728895 Dose Finding Study of Vedolizumab for GvHD in Participants Undergoing Allogeneic HSCT Status COMPLETED Phase PHASE1